Financhill
Buy
73

CHMG Quote, Financials, Valuation and Earnings

Last price:
$55.74
Seasonality move :
1.9%
Day range:
$52.66 - $53.50
52-week range:
$40.71 - $55.48
Dividend yield:
2.41%
P/E ratio:
19.31x
P/S ratio:
1.85x
P/B ratio:
1.05x
Volume:
8.3K
Avg. volume:
7.5K
1-year change:
-2.94%
Market cap:
$256.4M
Revenue:
$150.4M
EPS (TTM):
$2.77

Earnings Data

Next earnings date for CHMG
Jan 27
2026
Most recent earnings per share
$1.60
Missed by $0.01
(Oct 21/2025)
Consensus Estimate
$1.61
(Oct 21/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CHMG Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
01/27/2026 Q4 $29.5M -- -- $1.62 --
10/21/2025 Q3 $28.1M $39.8M $1.60 $1.61 -$0.01
07/17/2025 Q2 -- $22.2M -$1.32 $1.33 -$2.65
04/18/2025 Q1 $25.6M $37.6M $1.26 $1.20 $0.06
01/28/2025 Q4 $25M $38.7M $1.24 $1.21 $0.03
10/22/2024 Q3 $24.3M $38.1M $1.20 $1.13 $0.07
07/18/2024 Q2 $24.1M $37M $1.05 $1.12 -$0.07
04/18/2024 Q1 $23.7M $36.7M $1.48 $1.04 $0.44
01/25/2024 Q4 $23.2M $35.8M $0.80 $1.12 -$0.32
10/24/2023 Q3 -- $36.9M $1.61 -- --
06/30/2023 Q2 -- $33.3M $1.33 -- --
03/31/2023 Q1 -- $31.5M $1.54 -- --
12/31/2022 Q4 -- $29.8M $1.58 -- --
09/30/2022 Q3 -- $26.1M $1.38 -- --
06/30/2022 Q2 -- $24.1M $1.71 -- --
03/31/2022 Q1 -- $23.3M $1.46 -- --
12/31/2021 Q4 -- $23.4M $1.38 -- --
09/30/2021 Q3 -- $23.6M $1.42 -- --
06/30/2021 Q2 -- $23.3M $1.45 -- --
03/31/2021 Q1 -- $22.3M $1.39 -- --
12/31/2020 Q4 -- $23.3M $1.11 -- --
09/30/2020 Q3 -- $21.9M $1.20 -- --
06/30/2020 Q2 -- $21.2M $1.20 -- --
03/31/2020 Q1 -- $21.4M $0.51 -- --
12/31/2019 Q4 -- $21.8M $0.86 -- --
09/30/2019 Q3 -- $21.8M $0.40 -- --
06/30/2019 Q2 -- $21.8M $1.02 -- --
03/31/2019 Q1 -- $21.5M $0.92 -- --
12/31/2018 Q4 -- $22M $1.18 -- --
09/30/2018 Q3 -- $21.3M $1.43 -- --
06/30/2018 Q2 -- $21.1M $0.52 -- --
03/31/2018 Q1 -- $21M $0.92 -- --
12/31/2017 Q4 -- $20.9M -$0.45 -- --
09/30/2017 Q3 -- $20.7M $0.76 -- --
06/30/2017 Q2 -- $19.7M $0.62 -- --
03/31/2017 Q1 -- $19.1M $0.62 -- --
12/31/2016 Q4 -- $19.1M $0.62 -- --
09/30/2016 Q3 -- $19.4M $0.58 -- --
06/30/2016 Q2 -- $19.1M $0.34 -- --
03/31/2016 Q1 -- $19.5M $0.57 -- --
12/31/2015 Q4 -- $18.9M $0.45 -- --

Chemung Financial Corp. Earnings Questions

  • How Much did Chemung Financial Corp. Generate in Revenue Last Quarter?

    Chemung Financial Corp. reported $39.8M worth of top line sales in its most recent quarter.

  • Did Chemung Financial Corp. Beat Earnings Last Quarter?

    Chemung Financial Corp. announced earnings per share of $1.60 which represents a miss of analyst forecast a $1.61 per share.

  • Is Chemung Financial Corp. Profitable?

    Chemung Financial Corp. reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Chemung Financial Corp. EPS Next Year?

    Chemung Financial Corp.'s earnings are forecast to grow from $4.96 per share to $4.91 per share next year representing an increase of 17.78%.

  • When is Chemung Financial Corp.'s Earnings Date?

    Chemung Financial Corp.'s next earnings date is January 27, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Did Netflix Buy Warner Bros?
Why Did Netflix Buy Warner Bros?

Following a bidding war, Netflix (NASDAQ:NFLX) has announced its intention…

Why Did SoFi Stock Drop?
Why Did SoFi Stock Drop?

Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…

Will Robinhood Win AI Investing?
Will Robinhood Win AI Investing?

Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…

Stock Ideas

Buy
54
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
56
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
59
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
67
GPCR alert for Dec 9

Structure Therapeutics, Inc. [GPCR] is down 4.73% over the past day.

Buy
62
SMX alert for Dec 9

SMX (Security Matters) Plc [SMX] is up 7.57% over the past day.

Buy
90
KYMR alert for Dec 9

Kymera Therapeutics, Inc. [KYMR] is down 7.87% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock